Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prevention of Coronary Artery in STENT Restenosis With the Combined Use of Pioglitazone and Sirolimus-Eluting Coronary Stent

NCT00376870 is registered in ClinicalTrials.gov with University of Rome Tor Vergata as lead sponsor.

NCT NCT00376870
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00376870 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prevention of Coronary Artery in STENT Restenosis With the Combined Use of Pioglitazone and Sirolimus-Eluting Coronary Stent
Lead sponsor
University of Rome Tor Vergata
Phase
Phase 3
Overall status
Unknown status
Start date
July 31, 2008
Completion date
April 30, 2011
Enrollment
160 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

coronary atherosclerosis, coronary restenosis, diabetes